RIVANNA Clinches Finalist Spot in Prestigious MedTech Innovator Competition

RIVANNA and the MedTech Innovator Competition

In an exciting development for the medical technology industry, RIVANNA®, a leading innovator in imaging-based medical technologies, announced that it has been chosen as a finalist in the highly regarded 2025 MedTech Innovator's Early-Stage Grand Prize competition. This achievement marks a significant milestone for the company, which is known for its groundbreaking advancements in enhancing medical imaging techniques.

MedTech Innovator (MTI) is recognized as the largest accelerator for medical technology companies globally, and being selected as a finalist is a testament to RIVANNA's commitment to pushing the boundaries of healthcare innovation. The announcement came on October 2, 2025, and highlighted RIVANNA's place among the top contenders in a competitive field that saw nearly 1,500 applications from startups worldwide. Only 64 of those were selected, representing the top 4% of medical innovations.

Competing for Innovation

RIVANNA is set to present its flagship product, the Accuro® 3S, during the finals of the MedTech Conference from October 5-8, 2025, in San Diego, California. The Accuro® 3S is touted as the first AI-enabled ultrasound guidance system specifically designed for extending ultrasound-guided regional anesthesia to critical procedures such as epidurals and spinal blocks. This innovative product not only points to RIVANNA’s technical capabilities but also emphasizes the company’s focus on improving patient care through advanced medical solutions.

As a finalist, RIVANNA is awarded $25,000 in non-dilutive funding, and has the chance to win the top honor, the Early-Stage Grand Prize, worth a remarkable $350,000. During the finals, the company will pitch its technology to a panel of industry experts, alongside a live voting session involving the audience to select the winner.

Statements from Leadership

Will Mauldin, Co-founder and CEO of RIVANNA, expressed immense pride and gratitude for this recognition. “It is an incredible honor to be selected as a finalist in MedTech Innovator's 2025 Early-Stage Grand Prize competition. This recognition not only validates the progress we have made in advancing Accuro 3S but also supports our mission to develop and commercialize world-first, imaging-based medical technologies that elevate global standards of care,” he stated.

This acknowledgment serves as a motivation for RIVANNA to continue pushing forward in their mission. The recognition comes at a time when the need for advanced healthcare solutions, especially those that leverage technology for enhanced patient outcomes, is paramount.

About RIVANNA

Founded and based in Charlottesville, Virginia, RIVANNA is dedicated to developing pioneering imaging-based medical devices aimed at improving healthcare delivery. Their focus on creating technologies that enable more effective medical interventions places them at the forefront of healthcare innovation.

Over the years, RIVANNA has successfully introduced comprehensive imaging solutions that cater to both early and late-stage interventions for spinal procedures and musculoskeletal diagnostics. By continually refining its technologies, RIVANNA is committed to setting new standards in patient care and safety.

MedTech Innovator and Its Impact

MedTech Innovator plays a vital role in the global healthcare ecosystem, fostering the development of technologies that transform patient care. With a mission centered on improving human health, MTI has processed nearly 14,000 applicants and nurtured over 700 graduates in its accelerator program. The startups that have emerged from MTI’s programs have collectively raised around $10 billion in follow-on funding, leading to the introduction of over 400 new products that benefit millions across the globe.

RIVANNA's participation in this competition aligns perfectly with MTI's vision of advancing healthcare. As innovations evolve, RIVANNA is poised to lead the charge toward revolutionary medical solutions.

To learn more about RIVANNA and its innovative technologies, please visit rivannamedical.com.